← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Sano Chemicals, Inc
College Station, TX
$4,166,931
Total funding
5
Grants
Funding over time
peak $1.2M · FY2016–24$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$4,166,931 · 5
By mechanism
R42$3,179,375 · 2
R41$987,556 · 3
Investigators at Sano Chemicals, Inc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
Preclinical Development of OCF001 for Treatment of Yeast Infections$983,345
R42 · FY2019 · AI
Preclinical Development of OCF001 for Treatment of Yeast Infections$965,515
R42 · FY2020 · AI
Preclinical Development of OCF001 for Treatment of Yeast Infections$930,515
R42 · FY2021 · AI
Preclinical Development of Occidiofungin for Treatment of Oral and Dermal Candidiasis$300,000
R42 · FY2024 · AI
Optimization of the Production and Isolation of the Novel Antifungal Occidiofungin$295,381
R41 · FY2016 · AI
Optimization of the Production and Isolation of the Novel Antifungal Occidiofungin$234,170
R41 · FY2017 · AI
A Novel Therapeutic Agent for the Treatment of Gram-positive Infections$233,066
R41 · FY2020 · AI
Lead Compound Discovery from Engineered Analogs of Occidiofungin$224,939
R41 · FY2017 · AI